SCHEMBL8869732

SCHEMBL8869732

O=C(Cc1ccccc1)NCCc1ccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCCO)nc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 6/20 0.53
CA1 P00915 4/20 0.52
CA2 P00918 4/20 0.52
CA5A P35218 2/20 0.52
CA7 P43166 2/20 0.52
CA5B Q9Y2D0 2/20 0.52
HIF1A Q16665 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
CA12 O43570 2/20 0.43
CA9 Q16790 2/20 0.43
LMNA P02545 1/20 0.43
CYP3A4 P08684 1/20 0.43
HTR1A P08908 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
NFKB1 P19838 1/20 0.43
CNR1 P21554 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869143 0.92 P4HTM (0.52) P4HTMCA1CA2CA5ACA7
SCHEMBL9139247 0.91 P4HTM (0.65) P4HTMCA1CA2CA5ACA7
SCHEMBL8869159 0.91 P4HTM (0.58) P4HTMHIF1ASMN1; SMN2NPC1RAB9A
SCHEMBL8869871 0.91 P4HTM (0.49) P4HTMCA1CA2CA5ACA7
SCHEMBL8868901 0.91 P4HTM (0.51) P4HTMCA1CA2CA5ACA7
SCHEMBL8867818 0.90 P4HTM (0.57) P4HTMCA1CA2HIF1ASMN1; SMN2
SCHEMBL8869248 0.89 P4HTM (0.47) P4HTMCA1CA2CA5ACA7
SCHEMBL8868789 0.88 P4HTM (0.48) P4HTMCA1CA2CA5ACA7
SCHEMBL8867352 0.88 POLB (0.52) P4HTMSMN1; SMN2NPC1RAB9ALMNA
SCHEMBL9144421 0.88 P4HTM (0.52) P4HTMCA1CA2CA5ACA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed